Literature DB >> 708572

Oncogenic transformation in vitro by the hypoxic cell sensitizer misonidazole.

R C Miller, E J Hall.   

Abstract

The hypoxic cell sensitizer Misonidazole (Ro-07-0582) induces oncogenic transformations in the C3H/10T1/2 mouse embryo cell line cultured in vitro. A drug concentration of 0.4 mM applied to aerated cells for 3 or 6 days results in a transformation rate comparable to that observed following an X-ray dose of 1 Gray. A higher drug concentration of 6.0 mM is equivalent to 4 Gy. The combination of Misonidazole and X-rays produces a significant increase in the frequency of transformation over either drug or radiation alone, but the data are equivocal on the question of additivity vs synergism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708572      PMCID: PMC2009745          DOI: 10.1038/bjc.1978.222

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  HYDRATED ELECTRONS AND RADIOBIOLOGICAL SENSITISATION.

Authors:  G E ADAMS; D L DEWEY
Journal:  Biochem Biophys Res Commun       Date:  1963-08-20       Impact factor: 3.575

Review 2.  Chemical radiosensitization of hypoxic cells.

Authors:  G E Adams
Journal:  Br Med Bull       Date:  1973-01       Impact factor: 4.291

3.  The mutagenic action of nitroimidazoles. I. Metronidazole, nimorazole, dimetridazole and ronidazole.

Authors:  C E Voogd; J J Van der Stel; J J Jacobs
Journal:  Mutat Res       Date:  1974-12       Impact factor: 2.433

4.  Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division.

Authors:  C A Reznikoff; D W Brankow; C Heidelberger
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

5.  Chemical radioprotection and radiosensitization of mammalian cells growing in vitro.

Authors:  J D Chapman; A P Reuvers; J Borsa; C L Greenstock
Journal:  Radiat Res       Date:  1973-11       Impact factor: 2.841

6.  Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division.

Authors:  C A Reznikoff; J S Bertram; D W Brankow; C Heidelberger
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

7.  The contribution of metronidazole and two metabolites to the mutagenic activity detected in urine of treated humans and mice.

Authors:  T H Connor; M Stoeckel; J Evrard; M S Legator
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

8.  Cytotoxicity of Ro-07-0582; enhancement by hyperthermia and protection by cysteamine.

Authors:  E J Hall; M Astor; C Geard; J Biaglow
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

9.  The histological structure of some human lung cancers and the possible implications for radiotherapy.

Authors:  R H THOMLINSON; L H GRAY
Journal:  Br J Cancer       Date:  1955-12       Impact factor: 7.640

10.  Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.

Authors:  P W Sheldon; J L Foster; J F Fowler
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

View more
  2 in total

1.  Oncogenic transformation of mammalian cells in vitro with split doses of x-rays.

Authors:  R C Miller; E J Hall; H H Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

2.  Cell-cycle inhibition by misonidazole of human cells cultivated in vitro under aerobic conditions.

Authors:  T Lindmo; E O Pettersen; E Wibe
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.